Kobe ​Thyroid Cytology Club

Hirokawa M, Niioka H, Suzuki A, Abe M, Arai Y, Nagahara H, Miyauchi A, Akamizu T.

Application of deep learning as an ancillary diagnostic tool for thyroid FNA cytology.

Cancer Cytopathol. 2023 Apr;131(4):217-225.

​

Nakaizumi N, Fukata S, Hirokawa M, Akamizu T.

Painless thyroiditis incidentally diagnosed following SARS-CoV-2 infection.

BMJ Case Rep. 2022 Dec 1;15(12):e252837. 

​

Ito Y, Miyauchi A, Hirokawa M, Kihara M, Onoda N, Miya A.

Clinicopathological features and outcomes of intrathyroidal thymic carcinoma: a single institution study.

Endocr J. 2022;69:1351-1356.

​

Yamamoto M, Onoda N, Miyauchi A, Fujishima M, Hayashi T, Hirokawa M.

Gauze blotting technique: a novel method to identify parathyroid glands during thyroid surgery without tissue damage.

Endocr J. 2022 Nov 28;69(11):1329-1333.

​

Onoda N, Hirokawa M, Miya A, Sasaki T, Fujishima M, Masuoka H, Higashiyama T, Kihara M, Miyauchi A.

Lipoadenoma of the parathyroid: characteristics of a rare cause of hyperparathyroidism.

Endocr J. 2022;69:1227-1232.

​

Ito Y, Hirokawa M, Masuoka H, Higashiyama T, Kihara M, Onoda N, Miya A, Miyauchi A.

Prognostic factors for follicular thyroid carcinoma: the importance of vascular invasion.

Endocr J. 2022;69:1149-1156.

​

Kihara M, Miyauchi A, Hirokawa M, Fujishima M, Masuoka H, Higashiyama T, Onoda N, Ito Y, Miya A.

Metastatic papillary thyroid carcinoma presenting with elevated serum levels of carbohydrate antigen 19-9 (CA19-9): a case report.

Surg Case Rep. 2022;8:45.

​

Suzuki A, Hirokawa M, Furutate M, Hirai Y, Miyauchi A.

LC-1000 flow cytometry system improves risk stratification of thyroid nodules with suspected follicular neoplasm.

JMA J. 2022;5(1):124-126.

​

Suzuki A, Hirokawa M, Kanematsu R, Tanaka A, Yamao N, Higuchi M, Hayashi T, Kuma S, Miyauchi A.

B-cell to T-cell ratio as a novel indicator in flow cytometry in the diagnosis of thyroid lymphoma.

Endocr J. 2022;69(3):291-297.

​

Kamma H, Kameyama K, Kondo T, Imamura Y, Nakashima M, Chiba T, Hirokawa M.

Pathological diagnosis of general rules for the description of thyroid cancer by Japanese Society of Thyroid Pathology and Japan Association of Endocrine Surgery.

Endocr J. 2022;69(2):139-154.

​

Hirokawa M, , Suzuki A, Kawakami M, Kudo T, Miyauchi A. 

Criteria for follow-up of thyroid nodules diagnosed as follicular neoplasm without molecular testing – The experience of a high-volume thyroid centre in Japan

Diagnostic Cytopathology. 2022;50:223–229.

​

Ito Y, Hirokawa M, Hayashi T, Kihara M, Onoda N, Miya A, Miyauchi A.

Clinical outcomes of follicular tumor of uncertain malignant potential of the thyroid: real-world data.

Endocr J. 2022;69:757-761. 

​

Yoshikawa KI, Tanimura T, Hoshi M, Fukumori T, Shimizu K, Ishii S, Onose H, Yamada E, Sugishita Y, Suzuki S, Hirokawa M, Miyauchi A, Yamada T.

Melanin-producing medullary thyroid carcinoma with transformation to melanoma: A case report.

Mol Clin Oncol. 2022;16:34.

​

Nishihara E, Hobo Y, Miyauchi A, Ito Y, Higuchi M, Hirokawa M, Ito M, Fukata S, Nishikawa M, Akamizu T.

Serum thyroglobulin evaluation on LC-MS/MS and immunoassay in TgAb-positive patients with papillary thyroid carcinoma.

Eur Thyroid J. 2022;11:e210041.

​

Hirokawa M, Higuchi M, Suzuki A, Hayashi T, Kuma S, Miyauchi A.

Papillary Thyroid Carcinoma with Honeycomb-Like Growth: Clinicopathological Characteristics and Diagnostic Significance as a Novel Variant

Pathobiology. 2022;89(2):107-115.